Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity

PLoS One. 2013 Jul 4;8(7):e67937. doi: 10.1371/journal.pone.0067937. Print 2013.

Abstract

Antilipopolysaccharide factors (ALFs) have been described as highly cationic polypeptides with a broad spectrum of potent antimicrobial activities. In addition, ALFs have been shown to recognize LPS, a major component of the Gram-negative bacteria cell wall, through conserved amino acid residues exposed in the four-stranded β-sheet of their three dimensional structure. In penaeid shrimp, ALFs form a diverse family of antimicrobial peptides composed by three main variants, classified as ALF Groups A to C. Here, we identified a novel group of ALFs in shrimp (Group D ALFs), which corresponds to anionic polypeptides in which many residues of the LPS binding site are lacking. Both Group B (cationic) and Group D (anionic) shrimp ALFs were produced in a heterologous expression system. Group D ALFs were found to have impaired LPS-binding activities and only limited antimicrobial activity compared to Group B ALFs. Interestingly, all four ALF groups were shown to be simultaneously expressed in an individual shrimp and to follow different patterns of gene expression in response to a microbial infection. Group B was by far the more expressed of the ALF genes. From our results, nucleotide sequence variations in shrimp ALFs result in functional divergence, with significant differences in LPS-binding and antimicrobial activities. To our knowledge, this is the first functional characterization of the sequence diversity found in the ALF family.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology*
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / genetics*
  • Antimicrobial Cationic Peptides / pharmacology
  • Cell Wall / chemistry
  • Fungi / drug effects
  • Fungi / growth & development
  • Gene Expression
  • Genetic Variation
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / growth & development
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / growth & development
  • Hemocytes / chemistry*
  • Hemocytes / immunology
  • Hemocytes / metabolism
  • Lipopolysaccharides / antagonists & inhibitors*
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Penaeidae / genetics*
  • Penaeidae / immunology
  • Protein Binding
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Sequence Alignment
  • Sequence Homology, Amino Acid

Substances

  • Anti-Infective Agents
  • Antimicrobial Cationic Peptides
  • Lipopolysaccharides
  • Recombinant Proteins

Grants and funding

This study received financial support from IFREMER and CNRS. RDR was supported by a doctoral fellowship from CNPq-Brazil and PG by a master fellowship provided by CAPES Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.